# US 2017/0253639 A1 · Nutritive Fragments, Proteins and Methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253639 A1
- Document ID: US20170253639A1
- Status: Published application
- Kind: A1
- Application number: 15/429,412
- Filed: 2017-02-10
- Published: 2017-09-07
- Earliest claimed: 2012-03-26
- Assignees: Axcella Health Inc.
- Applicants: Axcella Health Inc.
- Inventors: David Arthur Berry; Brett Adam Boghigian; Nathaniel W. Silver; Geoffrey von Maltzahn; Rajeev Chillakuru; Michael Hamill; John F. Kramarczyk
- Web page: https://patentgrep.com/patent/US20170253639A1

## CPC

- C07K 14/435: from animals; from humans
- A23L 33/17: Amino acids, peptides or proteins
- A23L 33/18: Peptides; Protein hydrolysates
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 38/1709: {from mammals}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Nutritive proteins are provided. In some embodiments the nutritive proteins comprise a first polypeptide sequence comprising a fragment of a naturally-occurring nutritive protein. In some embodiments the fragment comprises at least one of a) an enhanced ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein; b) an enhanced ratio of leucine residues to total amino acid residues present in the nutritive protein; and c) an enhanced ratio of essential amino acid residues to total amino acid residues present in the nutritive protein. In some embodiments, the fragment comprises at least one of a) a ratio of branch chain amino acid residues to total amino acid residues present in the nutritive protein; b) a ratio of leucine residues to total amino acid residues present in the nutritive protein; and c) a ratio of essential amino acid residues to total amino acid residues present in the nutritive protein, that is equal to or greater than the corresponding ratio present in a benchmark protein such as whey, egg or soy protein. Also provided are nucleic acids encoding the proteins, recombinant microorganisms that make the proteins, methods of making the proteins using recombinant microorganisms, compositions that comprise the proteins, and methods of using the proteins, among other things.

## Claims

### Claim 1

An isolated nutritive protein comprising a first polypeptide comprising a first polypeptide sequence that is homologous to a fragment of a naturally-occurring protein, wherein the fragment is at least 25 amino acids in length, wherein the first polypeptide sequence comprises at least one of:
a. a ratio of branch chain amino acid residues to total amino acid residues of at least 24%;
b. a ratio of Leu residues to total amino acid residues of at least 11%; and
c. a ratio of essential amino acid residues to total amino acid residues of at least 49%,
and wherein the first polypeptide sequence has less than 90% global homology to a known allergen.

### Claim 2 (depends on 1)

The isolated nutritive protein of claim 1, wherein the first polypeptide sequence further comprises at least one of each essential amino acid.

### Claim at position 3

-4. (canceled)

### Claim 5 (depends on 1)

The isolated nutritive protein of claim 1, wherein the fragment of a naturally-occurring protein comprises at least 25 amino acid residues.

### Claim 6 (depends on 1)

The isolated nutritive protein of claim 1, wherein the fragment of a naturally-occurring protein comprises at least 50 amino acid residues.

### Claim 7 (depends on 1)

The isolated nutritive protein of claim 1, wherein the first polypeptide sequence comprises:
a. a ratio of branch chain amino acid residues to total amino acid residues of at least 24%;
b. a ratio of Leu residues to total amino acid residues of at least 11%; and
c. a ratio of essential amino acid residues to total amino acid residues of at least 49%.

### Claim at position 7

-69. (canceled)

### Claim 70 (depends on 1)

An isolated nucleic acid comprising a nucleic acid sequence that encodes a nutritive protein according to claim 1.

### Claim at position 9

-74. (canceled)

### Claim 75 (depends on 1)

A vector comprising a nucleic acid sequence that encodes a nutritive protein of claim 1.

### Claim 76

(canceled)

### Claim 77 (depends on 70)

A recombinant microorganism comprising the nucleic acid of claim 70.

### Claim at position 13

-81. (canceled)

### Claim 82 (depends on 77)

A method of making a nutritive protein, the method comprising culturing a recombinant microorganism according to claim 77 under conditions sufficient for production of the nutritive protein by the recombinant microorganism.

### Claim 83

(canceled)

### Claim 84 (depends on 1)

A nutritive composition comprising a nutritive protein of claim 1 and at least one second component.

### Claim at position 17

-100. (canceled)

### Claim 101 (depends on 1)

A method of making a nutritive composition, comprising providing a nutritive protein according to claim 1 and combining the nutritive protein with the at least one second component.

### Claim 102 (depends on 1)

A method of maintaining or increasing at least one of muscle mass, muscle strength, and functional performance in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein of claim 1.

### Claim 103 (depends on 1)

A method of maintaining or achieving a desirable body mass index in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein of claim 1.

### Claim 104

(canceled)

### Claim 105 (depends on 1)

A method of providing protein to a subject with protein-energy malnutrition, the method comprising providing to the subject a sufficient amount of a nutritive protein of claim 1.

### Claim 106 (depends on 1)

A method of increasing thermogenesis in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein of claim 1.

### Claim 107 (depends on 1)

A method of inducing at least one of a satiation response and a satiety response in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein of claim 1.

### Claim at position 25

-109. (canceled)

### Claim 110 (depends on 1)

A method of treating at least one of cachexia, sarcopenia and frailty in a subject, the method comprising providing to the subject a sufficient amount of a nutritive protein of any one of claim 1.

### Claim 111

(canceled)

### Claim 112 (depends on 1)

A method of making a nutritive protein of claim 1, the method comprising chemically synthesizing the protein.

### Claim 113 (depends on 1)

A method of making a nutritive protein of claim 1, the method comprising isolating the protein.

### Claim 114 (depends on 1)

The isolated nutritive protein of claim 1, wherein the first polypeptide sequence is at least 25 amino acids in length.
